Literature DB >> 21679916

Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study.

Farzana Choudhury1, Rohit Varma2, Roberta McKean-Cowdin1, Ronald Klein3, Stanley P Azen4.   

Abstract

PURPOSE: To identify risk factors for 4-year incidence and progression of age-related macular degeneration (AMD) in adult Latinos.
DESIGN: Population-based prospective cohort study.
METHODS: Participants, aged 40 or older, from The Los Angeles Latino Eye Study (LALES) underwent standardized comprehensive ophthalmologic examinations at baseline and at 4 years of follow-up. Age-related macular degeneration was detected by grading 30-degree stereoscopic fundus photographs using the modified Wisconsin Age-Related Maculopathy Grading System. Multivariate stepwise logistic regression was used to examine the independent association of incidence and progression of AMD and baseline sociodemographic, behavioral, clinical, and ocular characteristics.
RESULTS: Multivariate analyses revealed that older age (OR per decade of age: 1.52; 95% CI: 1.29, 1.85) and higher pulse pressure (OR per 10 mm Hg: 2.54; 95% CI: 1.36, 4.76) were independently associated with the incidence of any AMD. The same factors were associated with early AMD, soft indistinct drusen, and retinal pigmentary abnormalities. Additionally, presence of clinically diagnosed diabetes mellitus was independently associated with increased retinal pigment (OR: 1.66; 95% CI: 1.01, 2.85), and male gender was associated with retinal pigment epithelial depigmentation (OR 2.50; 95% CI: 1.48, 4.23). Older age (OR per decade of age: 2.20; 95% CI: 1.82, 2.67) and current smoking (OR: 2.85; 95% CI: 1.66, 4.90) were independently associated with progression of AMD.
CONCLUSIONS: Several modifiable risk factors were associated with 4-year incidence and progression of AMD in Latinos. The results suggest that interventions aimed at reducing pulse pressure and promoting smoking cessation may reduce incidence and progression of AMD, respectively.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21679916      PMCID: PMC3159714          DOI: 10.1016/j.ajo.2011.02.025

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  46 in total

1.  Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease.

Authors:  Nicole Tedeschi-Blok; Jonathan Buckley; Rohit Varma; Timothy J Triche; David R Hinton
Journal:  Ophthalmology       Date:  2007-01       Impact factor: 12.079

2.  Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study.

Authors:  Rohit Varma; Athena W P Foong; Mei-Ying Lai; Farzana Choudhury; Ronald Klein; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2010-05       Impact factor: 5.258

3.  Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study.

Authors:  Rohit Varma; Farzana Choudhury; Ronald Klein; Jessica Chung; Mina Torres; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2010-02-10       Impact factor: 5.258

4.  Ocular risk factors for age-related macular degeneration: the Los Angeles Latino Eye Study.

Authors:  Samantha Fraser-Bell; Farzana Choudhury; Ronald Klein; Stanley Azen; Rohit Varma
Journal:  Am J Ophthalmol       Date:  2010-02-06       Impact factor: 5.258

5.  Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study.

Authors:  Vikas Chopra; Rohit Varma; Brian A Francis; Joanne Wu; Mina Torres; Stanley P Azen
Journal:  Ophthalmology       Date:  2007-08-22       Impact factor: 12.079

6.  Influence of diabetes and cardiovascular disease on the long-term incidence of cataract: the Blue Mountains eye study.

Authors:  Jennifer S L Tan; Jie Jin Wang; Paul Mitchell
Journal:  Ophthalmic Epidemiol       Date:  2008 Sep-Oct       Impact factor: 1.648

7.  Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study.

Authors:  Samantha Fraser-Bell; Joanne Wu; Ronald Klein; Stanley P Azen; Claire Hooper; Athena W P Foong; Rohit Varma
Journal:  Am J Ophthalmol       Date:  2008-02       Impact factor: 5.258

8.  Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Amanda A Honeycutt; Sarah B Lesesne; Jinan Saaddine
Journal:  Arch Ophthalmol       Date:  2009-04

9.  Age-related macular degeneration.

Authors:  Hanna R Coleman; Chi-Chao Chan; Frederick L Ferris; Emily Y Chew
Journal:  Lancet       Date:  2008-11-22       Impact factor: 79.321

Review 10.  Quality of life in age-related macular degeneration: a review of the literature.

Authors:  Jan Mitchell; Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2006-12-21       Impact factor: 3.186

View more
  17 in total

1.  Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.

Authors:  Fridbert Jonasson; Diana E Fisher; Gudny Eiriksdottir; Sigurdur Sigurdsson; Ronald Klein; Lenore J Launer; Tamara Harris; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2014-04-24       Impact factor: 12.079

2.  Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): results from the National Health and Nutrition Examination Survey 2005-2008.

Authors:  D T Q Barbosa; T S Mendes; H R Cíntron-Colon; S Y Wang; R B Bhisitkul; K Singh; S C Lin
Journal:  Eye (Lond)       Date:  2014-02-07       Impact factor: 3.775

Review 3.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

4.  Drusen and RPE atrophy automated quantification by optical coherence tomography in an elderly population.

Authors:  B Diniz; D C Rodger; V R Chavali; T MacKay; S Y Lee; D Stambolian; S V R Sadda
Journal:  Eye (Lond)       Date:  2014-11-07       Impact factor: 3.775

5.  Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study.

Authors:  Wanjiku Mathenge; Andrew Bastawrous; Tunde Peto; Irene Leung; Allen Foster; Hannah Kuper
Journal:  PLoS Med       Date:  2013-02-19       Impact factor: 11.069

6.  Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).

Authors:  Vera L Bonilha; Karen G Shadrach; Mary E Rayborn; Yong Li; Gayle J T Pauer; Stephanie A Hagstrom; Sanjoy K Bhattacharya; Joe G Hollyfield
Journal:  Exp Eye Res       Date:  2013-04-03       Impact factor: 3.467

7.  Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration.

Authors:  Yanhui Deng; Ping Shuai; Haixin Wang; Shanshan Zhang; Jie Li; Mingyan Du; Peirong Huang; Chao Qu; Lulin Huang
Journal:  Aging (Albany NY)       Date:  2021-05-04       Impact factor: 5.682

Review 8.  Adaptive optics technology for high-resolution retinal imaging.

Authors:  Marco Lombardo; Sebastiano Serrao; Nicholas Devaney; Mariacristina Parravano; Giuseppe Lombardo
Journal:  Sensors (Basel)       Date:  2012-12-27       Impact factor: 3.576

9.  Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration.

Authors:  Takashi Tsuchihashi; Keisuke Mori; Kuniko Horie-Inoue; Yasushi Okazaki; Takuya Awata; Satoshi Inoue; Shin Yoneya
Journal:  Clin Ophthalmol       Date:  2014-12-05

Review 10.  Posterior segment eye disease in sub-Saharan Africa: review of recent population-based studies.

Authors:  Andrew Bastawrous; Philip I Burgess; Abdull M Mahdi; Fatima Kyari; Matthew J Burton; Hannah Kuper
Journal:  Trop Med Int Health       Date:  2014-01-31       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.